Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Deoxycytidine Kinase (DCK) Peptid

DCK Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN936955

Kurzübersicht für Deoxycytidine Kinase (DCK) Peptid (ABIN936955)

Target

DCK (Deoxycytidine Kinase (DCK))

Spezies

Säugetier

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein-Typ

    Synthetic

    Sequenz

    ATPETCLHRI YLRGRNEEQG IPLEYLEKLH YKHESWLLHR TLKTNFDYLQ

    Produktmerkmale

    A synthetic peptide for use as a blocking control in assays to test for specificity of DCK antibody,
    Alternative Names: DCK control peptide, DCK antibody Blocking Peptide, Anti-DCK Blocking Peptide, Deoxycytidine Kinase Blocking Peptide, MGC117410 Blocking Peptide, MGC138632 Blocking Peptide
  • Applikationshinweise

    Optimal conditions should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20 °C long term.
  • Target

    DCK (Deoxycytidine Kinase (DCK))

    Hintergrund

    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

    Molekulargewicht

    30 kDa
Sie sind hier:
Chat with us!